PARTH PATEL: Open Payments
NPI 1447744453 · PHILADELPHIA, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$28,842 in 203 payments from 21 companies in 2025. Trend: 2023 $871 · 2024 $13,619 · 2025 $28,842
Speaker / faculty: $20,925Food & beverage: $4,781Travel & lodging: $1,987Consulting: $1,050Education: $99
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 65 | $24,627 |
| Arcutis Biotherapeutics, Inc. | 2 | $1,172 |
| LEO Pharma Inc. | 20 | $612 |
| ABBVIE INC. | 21 | $381 |
| GENZYME CORPORATION | 7 | $307 |
| MAYNE PHARMA COMMERCIAL LLC | 12 | $260 |
| UCB, Inc. | 5 | $225 |
| Novartis Pharmaceuticals Corporation | 11 | $219 |
| Organon LLC | 14 | $186 |
| Lilly USA, LLC | 10 | $174 |
Products named: TREMFYA, Zoryve, ADBRY, DUPIXENT, Bimzelx, COSENTYX, TALTZ, SKYRIZI.
Industry payments across PA — which companies pay providers there.
